There’s a lot of fear around applying artificial intelligence to the life sciences.

And while Diogo Rau concedes that there are risks associated with using AI, the biggest risk is that we won’t use it.

Diogo Rau is EVP and Chief Information and Digital Officer of Eli Lilly & Company, where he leads their information technology, cybersecurity, digital health, advanced analytics and data science functions.

Prior to joining Lilly, Diogo served as Head of Engineering for Apple Retail and Partner at McKinsey & Company.

On this episode of The Beat, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world.

Diogo explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly.

Listen in for Diogo’s insight on using tech to inspire behavior change in patients and learn how we might leverage AI to generate new medicines, improve clinical trials and facilitate personalized medicine.